Aripiprazole monotherapy in acute bipolar I mania: A randomized, placebo- & lithium-controlled study (Cn138-135)

被引:0
|
作者
Hanssens, L. [1 ]
Torbeyns, A. [1 ]
Marcus, R. N. [2 ]
McQuade, R. D. [3 ]
Sanchez, R. [4 ]
机构
[1] Bristol Myers Squibb Co, Braine LAlleud, Belgium
[2] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
[3] Otsuka Pharmaceut Dev & Commercializat Inc, Princeton, NJ USA
[4] Bristol Myers Squibb Co, Rueil Malmaison, France
关键词
D O I
10.1016/j.eurpsy.2008.01.416
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:S229 / S229
页数:1
相关论文
共 50 条
  • [21] A 12-WEEK, RANDOMIZED, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF ARIPIPRAZOLE IN COMBINATION WITH LITHIUM/VALPROATE IN PARTIALLY-RESPONSIVE BIPOLAR MANIA
    Loze, J. -Y.
    Landsberg, W.
    Rollin, L.
    Eudicone, J. M.
    Carson, W. H.
    McQuade, R. D.
    EUROPEAN PSYCHIATRY, 2013, 28
  • [22] Metabolic effects of long-term treatment of patients with bipolar disorder with either lithium or aripiprazole (CN138-135LT)
    McIntyre, R. S.
    McElroy, S. L.
    Pikalov, A.
    Whitehead, R.
    Carlson, B. X.
    Eudicone, J.
    Baker, R. A.
    BIPOLAR DISORDERS, 2009, 11 : 62 - 62
  • [23] Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study
    Sachs, G
    Chengappa, KNR
    Suppes, T
    Mullen, JA
    Brecher, M
    Devine, NA
    Sweitzer, DE
    BIPOLAR DISORDERS, 2004, 6 (03) : 213 - 223
  • [24] A randomized, placebo- and active-controlled study of paliperidone extended release for the treatment of acute manic and mixed episodes of bipolar I disorder
    Vieta, Eduard
    Nuamah, Isaac F.
    Lim, Pilar
    Yuen, Eric C.
    Palumbo, Joseph M.
    Hough, David W.
    Berwaerts, Joris
    BIPOLAR DISORDERS, 2010, 12 (03) : 230 - 243
  • [25] A 46-week safety, efficacy and functional evaluation of adjunctive aripiprazole with lithium/valproate in bipolar mania (CN138-134LT)
    Owen, R.
    Baudelet, C.
    McQuade, R. D.
    Sanchez, R.
    Marcus, R. N.
    BIPOLAR DISORDERS, 2009, 11 : 67 - 67
  • [26] Asenapine treatment of bipolar mania in a randomized, double-blind, placebo- and olanzapine-controlled trial (ARES 7501005)
    Hirschfeld, R.
    Panagides, J.
    Alphs, L.
    Cohen, M.
    Lancaster, S.
    Macek, T.
    BIPOLAR DISORDERS, 2007, 9 : 53 - 53
  • [27] Aripiprazole for the treatment of pediatric bipolar I disorder: a 30-week, randomized, placebo-controlled study
    Findling, Robert L.
    Correll, Christoph U.
    Nyilas, Margaretta
    Forbes, Robert A.
    McQuade, Robert D.
    Jin, Na
    Ivanova, Svetlana
    Mankoski, Raymond
    Carson, William H.
    Carlson, Gabrielle A.
    BIPOLAR DISORDERS, 2013, 15 (02) : 138 - 149
  • [28] A Double-Blind, Placebo-Controlled Study of Quetiapine and Lithium Monotherapy in Adults in the Acute Phase of Bipolar Depression (EMBOLDEN I)
    Young, Allan H.
    McElroy, Susan L.
    Bauer, Michael
    Philips, Nabil
    Chang, William
    Olausson, Bengt
    Paulsson, Bjoern
    Brecher, Martin
    JOURNAL OF CLINICAL PSYCHIATRY, 2010, 71 (02) : 150 - 162
  • [29] Asenapine in the treatment of acute mania in bipolar I disorder: Outcomes from two randomized and placebo-controlled trials
    McIntyre, R.
    Hirschfeld, R.
    Alphs, L.
    Cohen, M.
    Macek, T.
    Panagides, J.
    JOURNAL OF AFFECTIVE DISORDERS, 2008, 107 : S56 - S56
  • [30] Asenapine in the treatment of acute mania in bipolar I disorder: Outcomes from two randomized placebo-controlled trials
    McIntyre, R.
    Hirschfeld, R.
    Alphs, L.
    Cohen, M.
    Macek, T.
    Panagides, J.
    BIPOLAR DISORDERS, 2008, 10 : 49 - 49